Back

Global Learning Collaborative

  • Alzheimer Disease

Reimagining Alzheimer’s Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy an Impact Live Series

Join this live session to examine practical approaches for integrating subcutaneous anti-amyloid therapies into the management of early Alzheimer s disease. Faculty present emerging evidence on subcutaneous administration, including efficacy and safety data and its potential to expand treatment access. The discussion reviews patient selection, APOE 4 risk stratification, MRI-based ARIA monitoring, and counseling considerations for patients and caregivers. Participants will also explore practical strategies for implementing subcutaneous anti-amyloid therapies in clinical practice while maintaining evidence-based monitoring and supporting treatment adherence.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No
Start Date
October 30, 2026
End Date
October 31, 2026

Pricing

Free

Reported to ACCME by the provider

  • Live
  • Credit · Up to 1 credit
  • Commercial Support
  • When
    Oct 30, 2026